VGNT
Versigent PLC
VGNT
Versigent PLC
Versigent delivered a strong first full quarter as an independent company, with sales up 10.8 percent and adjusted EBITDA up 24.8 percent. The stock is not as cheap as it was right after the Aptiv sep
Versigent NYSE: VGNT reported second-quarter results marked by double-digit sales growth, higher adjusted EBITDA margins and the launch of its first quarterly dividend as the newly independent company
Versigent is rated a buy with a $50/share target, leveraging operational improvements and sector diversification for revaluation upside. Temporary margin pressures from copper price lags are expected